HydrOXYzine Hydrochloride
- Product NDC
- 50090-2614
- Requested package NDC
- 50090-2614-0
- 11-digit product format
- 500902614
- Labeler code
- 50090
- Product ID
- 50090-2614_18cd1ec0-5aa3-4bb3-8415-ef4d9079e190
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- HydrOXYzine Hydrochloride
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- A-S Medication Solutions
- Application
- ANDA040840
- Marketing category
- ANDA
- Marketing start
- 2009-11-11
- Substance
- HYDROXYZINE DIHYDROCHLORIDE
- Active strength
- 50 mg/1
- Pharmacologic classes
- Antihistamine [EPC], Histamine Receptor Antagonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A040840-001 | HYDROXYZINE HYDROCHLORIDE | HYDROXYZINE HYDROCHLORIDE | 50MG | TABLET / ORAL | AB | 2008-03-31 | |
| A040840-002 | HYDROXYZINE HYDROCHLORIDE | HYDROXYZINE HYDROCHLORIDE | 10MG | TABLET / ORAL | AB | 2008-03-31 | |
| A040840-003 | HYDROXYZINE HYDROCHLORIDE | HYDROXYZINE HYDROCHLORIDE | 25MG | TABLET / ORAL | AB | 2008-03-31 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A040840-001 | AB |
| A040840-002 | AB |
| A040840-003 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A040840-001 | HYDROXYZINE HYDROCHLORIDE | 50MG | TABLET / ORAL | AB | 2008-03-31 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A040840-002 | HYDROXYZINE HYDROCHLORIDE | 10MG | TABLET / ORAL | AB | 2008-03-31 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A040840-003 | HYDROXYZINE HYDROCHLORIDE | 25MG | TABLET / ORAL | AB | 2008-03-31 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A040840-001 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A040840-002 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A040840-003 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| HydrOXYzine Hydrochloride | HYDROXYZINE HYDROCHLORIDE | A-S Medication Solutions | 5dea636d-dee6-47d4-b83c-b9f0c0b1b6ca | 2026-07-24 | Warnings, Adverse reactions | 040840 ANDA040840 |
| HydrOXYzine Hydrochloride | HYDROXYZINE HYDROCHLORIDE | A-S Medication Solutions | be6a2f09-c0f3-44e2-aac3-37e3702b93f0 | 2026-07-21 | Warnings, Adverse reactions | 040840 ANDA040840 50090-2614-0 50090-2614 50090261400 |
| HydrOXYzine Hydrochloride | HYDROXYZINE HYDROCHLORIDE | Redpharm Drug | 4fb58637-dc30-c4dd-e063-6394a90a8bbe | 2026-04-18 | Warnings, Adverse reactions | 040840 ANDA040840 |
| HydrOXYzine Hydrochloride | HYDROXYZINE HYDROCHLORIDE | Northstar RxLLC | 8e5fce17-936e-46ea-a969-518c952c2091 | 2025-12-23 | Warnings, Adverse reactions | 040840 ANDA040840 |
| HydrOXYzine Hydrochloride | HYDROXYZINE HYDROCHLORIDE | NuCare Pharmaceuticals,Inc. | acc99b8f-87f0-eb3a-e053-2995a90aaaed | 2025-11-20 | Warnings, Adverse reactions | 040840 ANDA040840 |
| HydrOXYzine Hydrochloride | HYDROXYZINE HYDROCHLORIDE | A-S Medication Solutions | 723b810b-46cc-4c45-ae1f-93ca358e007d | 2025-07-09 | Warnings, Adverse reactions | 040840 ANDA040840 |
| HydrOXYzine Hydrochloride | HYDROXYZINE HYDROCHLORIDE | REMEDYREPACK INC. | 58d99cf6-2319-410b-b8be-de9c304541b6 | 2025-06-17 | Warnings, Adverse reactions | 040840 ANDA040840 |
| HydrOXYzine Hydrochloride | HYDROXYZINE HYDROCHLORIDE | NuCare Pharmaceuticals,Inc. | ffd33207-3f35-3486-e053-6394a90ac0ae | 2025-02-05 | Warnings, Adverse reactions | 040840 ANDA040840 |
| HydrOXYzine Hydrochloride | HYDROXYZINE HYDROCHLORIDE | A-S Medication Solutions | 46266803-0905-4ae2-9d17-dbf4c2a08181 | 2023-09-07 | Warnings, Adverse reactions | 040840 ANDA040840 |
| HydrOXYzine Hydrochloride | HYDROXYZINE HYDROCHLORIDE | A-S Medication Solutions | 3d2e63c6-993c-42b9-91a0-616246789a7b | 2023-09-07 | Warnings, Adverse reactions | 040840 ANDA040840 |
| HydrOXYzine Hydrochloride | HYDROXYZINE HYDROCHLORIDE | Aphena Pharma Solutions - Tennessee, LLC | 8e954579-b0f5-4ce3-bade-0b9b972f6f8b | 2023-01-23 | Warnings, Adverse reactions | 040840 ANDA040840 |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- HydrOXYzine Hydrochloride
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| HYDROXYZINE HYDROCHLORIDE | 50 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 76755771U3 | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 995281 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| be6a2f09-c0f3-44e2-aac3-37e3702b93f0 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 57311cfb-679a-da1a-b70c-8757f7fc431a | Product name | 4 | 20250516 |
| aa1826f4-97c1-4705-bdf0-3bc7d234e618 | Product name | 2 | 20190618 |
| 75cb12ee-8eb2-4f1a-a332-5743a5d0da41 | Product name | 1 | 20151110 |
| 3ca5f78b-43dc-30fe-8014-55b922af52b3 | Product name | 1 | 20140508 |
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50090-2614-0 | HydrOXYzine Hydrochloride | 100 in 1 BOTTLE | TABLET | 100 | 19 | |
| 50090-2614-1 | HydrOXYzine Hydrochloride | 30 in 1 BOTTLE | TABLET | 30 | 19 | |
| 50090-2614-3 | HydrOXYzine Hydrochloride | 17 in 1 BOTTLE | TABLET | 17 | 19 | |
| 50090-2614-4 | HydrOXYzine Hydrochloride | 25 in 1 BOTTLE | TABLET | 25 | 19 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50090-2614-1 | EA - Each | 50090-2614 | 0c867062-7df7-4b52-843a-b059511f5f36 | 1 | 2019-04-11 |
| 50090-2614-4 | EA - Each | 50090-2614 | 963f30bc-3f18-4622-bac1-ba56f99cf3b3 | 1 | 2021-09-07 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 50090-2614 | HYDROXYZINE HYDROCHLORIDE TABLET [A-S MEDICATION SOLUTIONS] | 19 | Current NDC, Legacy NDC, 4 package rows | 20240530_be6a2f09-c0f3-44e2-aac3-37e3702b93f0.zip |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 995281 | hydrOXYzine HCl 50 MG Oral Tablet | PSN | be6a2f09-c0f3-44e2-aac3-37e3702b93f0 | 19 |
| 995281 | hydroxyzine hydrochloride 50 MG Oral Tablet | SCD | be6a2f09-c0f3-44e2-aac3-37e3702b93f0 | 19 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 50090-2614-0 | 50090261400 | 100 TABLET in 1 BOTTLE (50090-2614-0) | 100 tablet | 2018-10-19 | No | No | Current |